Comprehensive Overview of Lepu Biopharma’s ADC Drugs
Among the 12 ADC drugs approved by the FDA, 5 utilize Seagen’s VC-MMAE linker toxin platform. As a pioneer in global ADC drug development, one might ask if Seagen has any regrets?They might respond that they missed the opportunity to develop ADC drugs targeting the classic targets HER2 and EGFR, and instead, they can only … Read more